Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125879011 | 12587901 | 1 | I | 2015 | 20160712 | 20160725 | 20160725 | EXP | US-NOVOPROD-501580 | NOVO NORDISK | 62.00 | YR | A | F | Y | 74.83000 | KG | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125879011 | 12587901 | 1 | PS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | UNK UNK, QD | Y | UNKNOWN | 22341 | SOLUTION FOR INJECTION | QD | ||||||
| 125879011 | 12587901 | 2 | SS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 1.8 MG, QD | Y | UNKNOWN | 22341 | 1.8 | MG | SOLUTION FOR INJECTION | QD | ||||
| 125879011 | 12587901 | 3 | C | LEVEMIR | INSULIN DETEMIR | 1 | Subcutaneous | UNKNOWN | 0 | SOLUTION FOR INJECTION | |||||||||
| 125879011 | 12587901 | 4 | C | NOVOLOG | INSULIN ASPART | 1 | Subcutaneous | UNKNOWN | 0 | SOLUTION FOR INJECTION | |||||||||
| 125879011 | 12587901 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | UNK | UNKNOWN | 0 | |||||||||
| 125879011 | 12587901 | 6 | C | JARDIANCE | EMPAGLIFLOZIN | 1 | Oral | UNK, QD IN AM | UNKNOWN | 0 | QD | ||||||||
| 125879011 | 12587901 | 7 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | UNK | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125879011 | 12587901 | 1 | Type 2 diabetes mellitus |
| 125879011 | 12587901 | 3 | Type 2 diabetes mellitus |
| 125879011 | 12587901 | 4 | Type 2 diabetes mellitus |
| 125879011 | 12587901 | 5 | Type 2 diabetes mellitus |
| 125879011 | 12587901 | 6 | Type 2 diabetes mellitus |
| 125879011 | 12587901 | 7 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125879011 | 12587901 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125879011 | 12587901 | Abdominal pain upper | |
| 125879011 | 12587901 | Gastric polyps | |
| 125879011 | 12587901 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125879011 | 12587901 | 1 | 2015 | 2015 | 0 | |
| 125879011 | 12587901 | 2 | 2015 | 2016 | 0 |